CClinicalTrials.gg
CompletedNCT05722132Updated Apr 6, 2023

Latinos Kick Buts: Mobile Engagement and Cessation Support for Latinos Who Smoke

An interventional study of One cycle and 4 cycles in Smoking Cessation, sponsored by University of Rochester. Completed at 1 site in United States. Open to participants aged 21 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-04-06.

Sponsored by University of Rochester · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
2,826
Allocation
Randomized
Ages
21 Years and older
Sex
All
01

Study summary

Latino Kick Buts (LKB) is a smoking cessation treatment program available to Strong Memorial Hospital patients who smoke. LKB encompasses two integrated components: (1) a 12-week text messaging counseling program with interactive capabilities and (2) pharmacotherapy support (provision of nicotine replacement therapy at no cost). LKB utilization among Latinos who smoke remains minimal. This study aims to identify the types of text messages more effective in enrolling Latinos who smoke, identified in the electronic medical record, into LKB.

02

Conditions studied

  • Smoking Cessation
03

In context

Lead sponsor

University of Rochester is the lead sponsor of 715 studies on the registry; 116 are open to participants now.

Of its 56 completed or terminated interventional studies of FDA-regulated products, 44 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Adult Latinos who smoke and have received medical care at Strong Memorial Hospital/SHARP healthcare within the last year.
  • having smoking status recorded in the EMR

Exclusion criteria

Exclusion Criteria:

  • none
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Participant)
Enrollment
2,826 participants (actual)

Study arms

  • Active comparator
    One cycle-no monetary incentive

    Behavioral: One cycle

  • Active comparator
    One cycle-fixed amount of incentive

    Behavioral: One cycle · Behavioral: 5 Dollar Incentive

  • Active comparator
    One cycle-raffle as incentive

    Behavioral: One cycle · Behavioral: Raffle Incentive

  • Active comparator
    4 cycles- no monetary incentive

    Behavioral: 4 cycles

  • Active comparator
    4 cycles- fixed amount of incentive

    Behavioral: 4 cycles · Behavioral: 5 Dollar Incentive

  • Active comparator
    4 cycles- raffle as incentive

    Behavioral: 4 cycles · Behavioral: Raffle Incentive

Interventions

  • BehavioralOne cycle

    Message Design Participants will receive 3 messages per cycle that contain information on how to enroll in a cessation program.

  • Behavioral4 cycles

    Participants will receive 3 messages per cycle that contain information on how to enroll in a cessation program.

  • Behavioral5 Dollar Incentive

    Participants will receive 3 messages per cycle that contain information on how to enroll in a cessation program. The introductory message will mention that participants will receive $5 if they enroll in the program or that they should look out for messages with a "$" sign at the beginning that will provide an incentive if they respond.

  • BehavioralRaffle Incentive

    The incentive message (indicated with a leading "$" sign) will invite participants to respond, and participants that do so will be included in a random drawing depending on the condition. The incentive message for the opportunity to win will contain a link to a website that provides full details of the timing of the drawing, the chances of winning, and when notification of winners will be made.

06

What researchers measure

Primary outcomes

  1. Percentage of participant who enroll in cessation program

    Time frame: 16 weeks

07

Study locations

1 site
  • University of Rochester Medical Center
    Rochester, New York 14642, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05722132
Lead sponsor
University of Rochester
Collaborators
National Institute on Minority Health and Health Disparities (NIMHD)
Responsible party
Paula Cupertino (Professor, University of Rochester) — Principal investigator
First posted
Feb 10, 2023
Start date
Dec 27, 2022
Primary completion
Mar 25, 2023
Completion
Mar 25, 2023
Last update
Apr 6, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion